α-Therapy and Combination Strategies to Overcome Resistance and Enhance Clinical Outcomes in Prostate Cancer

Anna Karmann; Stephen Rose; Ken Herrmann; Clemens Kratochwil; Oliver Sartor; Shahneen Sandhu; Louise Emmett

doi:10.2967/jnumed.125.270940

Related publications

Article2021

Radionuclide Therapy in Prostate Cancer: From Standalone to Combination PSMA Theranostics

Shahneen Sandhu, Christina Guo, Michael S. Hofman

Article2009

Design Strategies of Novel NNRTIs to Overcome Drug Resistance

Peng Zhan, Xinyong Liu, Zhenyu Li, Christophe Pannecouque, De Clercq Erik

Chapter in a book2024

Chemoresistance, Radioresistance, and Androgen Deprivation Therapy Resistance in Prostate Cancer

Samaneh Adelian, Amin Soltani, Michael R Hamblin

Article2020

Combination therapy to enhance NK cell anti-tumor responses

Natalie K. Wolf, Chris J. Nicolai, Susanna M. Dang, Gail Synder, Cristina Blaj, Sarah M. McWhirter, Lora K. Picton, K. Christopher García, David H Raulet

Article2010

Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapy

Paweł Mróz, Ying‐Ying Huang, Angelika Szokalska, Timur Zhiyentayev, Sahar Janjua, Artemissia‐Phoebe Nifli, Margaret E. Sherwood, Christian Ruzié, K. Eszter Borbas, Dazhong Fan, Michael Krayer, Thiagarajan Balasubramanian, Eunkyung Yang, Hooi Ling Kee, Christine Kirmaier, James R. Diers, David F. Bocian, Dewey Holten, Jonathan S. Lindsey, Michael R Hamblin